Gadget Ogling: Same Old Apple

Welcome to Gadget Dreams and Nightmares, the column that prods and probes at the latest gadget announcements just in case there’s literally anything worth writing home about. In this glorious fall breeze of an edition, we take a look at the latest product suite to drift our way from the Apple hivemind, and one especially […]

Read More &#8594

48 hours in Yerevan, Armenia

Yerevan can be perplexing. Its neoclassical squares conjure Vienna, while its wide boulevards brim with Parisian élan. There’s no escaping the sprawl of brutal high-rises that shoulder its Soviet past, yet recent investment has embalmed the city’s rougher edges with glinting streets, a cable car and arts’ centre, all begging for exploration. Yerevan is known as […]

Read More &#8594

Are You Ready for a RoboCEO?

Here’s a disturbing thought: A RoboCEO powered by artificial intelligence — possibly based on IBM’s Watson — could be running some companies within the next decade. Not every company will warm to the idea, to be sure, but it’s conceivable that the practice could begin. Are you ready to work for a RoboCEO? Though it […]

Read More &#8594

The Science Of Sugar And Fat Loss

Having spent more than a decade in the fitness industry, I’ve seen every macronutrient demonized at various points. And the object of this demonization changes every few years. In the 1970s and ’80s it was fat, with protein caught in that undertow as well. In the late 1990s and early 2000s, carbohydrates were demonized, a […]

Read More &#8594

Exploring Delhi’s Eight Historic Cities

At first glance, Delhi embodies all that is exasperating and chaotic about modern India. It can take nerves of steel to face the frenetic pace at which it whirls through daily life. But grant Delhi a more discerning gaze and you’ll uncover a host of redeeming features. Topping the list is Delhi’s historical legacy, with the ruins […]

Read More &#8594

Metformin diabetes drug could extend lifespan

Metformin is approved in the US as a treatment for type 2 diabetes. A new study by Cardiff University, UK, involving over 180,000 people, reveals that the drug could also increase the lifespan of those individuals who are non-diabetics. According to the Centers for Disease Control and Prevention (CDC), there are around 29.1 million people […]

Read More &#8594